ACQUITY UPLC BEH125, BEH200 AND BEH450 SEC PROTEIN STANDARDS

Significance of the topic

Size exclusion chromatography remains a key method for analyzing monoclonal antibodies and aggregates in biopharma. High stability stationary phases with minimal secondary interactions ensure accurate molecular weight distribution profiles and reliable quality control.

Objectives and overview of the study

This work evaluates the performance of ACQUITY UPLC BEH125, BEH200 and BEH450 SEC columns in conjunction with dedicated protein standard mixes. Goals include establishing calibration across broad molecular weight ranges, benchmarking column efficiency, and demonstrating lot to lot reproducibility.

Methodology and instrumentation

The study employs an ACQUITY UPLC system configured for SEC analysis at 30 degrees celsius with a 100 millimolar sodium phosphate buffer at pH 6.8. Performance metrics are derived from test mixtures designed for each column chemistry and particle size. Key elements include

• BEH125 SEC 1.7 micrometer columns for 1 to 80 kDa range
• BEH200 SEC 1.7 micrometer columns for 10 to 450 kDa range
• BEH450 SEC 2.5 micrometer columns for 100 to 1500 kDa range
• Protein standard mixes featuring thyroglobulin, ovalbumin, ribonuclease A, IgG, BSA, myoglobin and uracil
• UV detection at 220 and 280 nanometers to monitor protein peaks
• Efficiency testing via theoretical plate count evaluation

Main results and discussion

Calibration curves show linear retention volume versus log molecular weight across all three BEH columns. Chromatograms demonstrate sharp, well resolved peaks with minimal tailing. Efficiency tests yield high theoretical plate counts that remain stable over multiple injections. Lot to lot and vial to vial reproducibility studies confirm excellent consistency in retention times and peak areas.

Benefits and practical applications

The BEH SEC column family together with matched protein mixes supports robust routine and in process analysis of proteins from peptides up to megaDalton complexes. The ready to use standard mixes streamline column qualification, system performance checks and ongoing QC monitoring, enhancing laboratory productivity.

Future trends and opportunities

Advances may focus on faster separations with sub two micrometer particles, coupling SEC with mass spectrometry for direct molecular characterization, and integration into automated workflows with real time data analytics. Development of new stationary phases could extend the usable molecular weight range beyond current limits.

Conclusion

The combination of ACQUITY UPLC BEH125, BEH200 and BEH450 SEC columns with bespoke protein standard mixes delivers reliable, high resolution size exclusion separations. This solution offers the reproducibility and performance demanded by modern biopharmaceutical research and quality control applications.